Stroke - Cell La Vie

079 月9 月 7, 2026

MSC Therapy for Ischemic Stroke: What a 2026 Umbrella Review and Network Meta-Analysis of 1,006 Patients Reveal

The 2026 evidence base for mesenchymal stem cell therapy in ischemic stroke includes a 26-study umbrella review and an 18-RCT network meta-analysis of 1,006 patients. MSCs were the only cell type to significantly reduce mortality. This medical review synthesizes the latest clinical data, mechanisms, active trials, and translational barriers.

间充质干细胞, 干细胞, Strokeclinical trial, immune system, MSC immunomodulation, MSC therapy, MSC, regenerative medicine, 干细胞, 干细胞

196 月6 月 19, 2026

Intravenous UC-MSCs for Ischemic Stroke: What the MERIT Phase 1 Trial Tells Us

The MERIT phase 1 trial published in Cell Reports Medicine shows that intravenous UC-MSC therapy is safe in subacute ischemic stroke, with early NIHSS improvement signals. Here’s what clinicians need to know.

间充质干细胞, 干细胞, Strokeimmune system, 间充质, MSC clinical outcomes, MSC, regenerative medicine, 干细胞, 干细胞, stem cells Thailand0 条评论

172 月2 月 17, 2025

Stem Cell Therapy ‘Jump-Starts’ Brain Repair After Stroke: A New Era in Neurological Recovery

Imagine a world where the devastating effects of a stroke could be reversed, even weeks after the event. This isn’t science fiction—it’s the promising reality emerging from groundbreaking research in stem cell therapy. A recent study has shown that stem cell treatment can effectively ‘jump-start’ brain repair processes, offering new...

干细胞, Stroke0 条评论

顶部